LynxCare
Clinical data analysis
LynxCare has raised €25M across 4 funding rounds from 7 investors, most recently a Series A round in Jun 2022. Based in Leuven, Belgium; active in Healthtech. Data as of 4 Nov 2026.
Leuven, Belgiumwww.lynxcare.eu ↗
Total raised
€25M
€24,750,000
Funding rounds
4
Investors
7
distinct backers
Active since
2017-10
latest 2022-06
Funding by year
EUR raised per yearLynxCare — funding by year — interactive chart.
Data table
| LynxCare — funding by year | |
|---|---|
| 2017 | €1.2M |
| 2019 | €1.8M |
| 2020 | €1.8M |
| 2022 | €20M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 11% (2+ rounds)
- ▲ 4 rounds raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-06-21 | Series A | €20M | btov Partners,Elaia Partners,Heran Partners,MTIP AG,PMV | View deal → |
| 2020-01-29 | Other | €1.8M | btov Partners | View deal → |
| 2019-04-01 | Other | €1.8M | — | View deal → |
| 2017-10-05 | Other | €1.2M | PMV,VLAIO | View deal → |
Related news
Similar companies
same sector, similar size- Confo Therapeutics€30MBelgium · Healthtech
- ExeVir Bio€25MBelgium · Healthtech
- Icometrix€18MBelgium · Healthtech
- Celyad Oncology€29MBelgium · Healthtech
- PDC*line Pharma€26MBelgium · Healthtech
- AstriVax€33MBelgium · Healthtech
Global coverage: FundingData